| Literature DB >> 27914902 |
Farida Djouad1, Natacha Ipseiz2, Patricia Luz-Crawford3, Carina Scholtysek4, Gerhard Krönke4, Christian Jorgensen5.
Abstract
Peroxisome proliferator-activated receptors (PPARs) have emerged as key regulators of physiological and immunological processes. Recently, one of their members PPARβ/δ has been identified as major player in the maintenance of bone homeostasis, by promoting Wnt signalling activity in osteoblast and mesenchymal stem cells (MSC). PPARβ/δ not only controls the fate of MSC but also regulates their immunosuppressive properties by directly modulating their NF-κB activity. In this review, we discuss how the regulation of PPARβ/δ provides an innovative strategy for an optimisation of MSC-based therapy.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27914902 DOI: 10.1016/j.biochi.2016.11.011
Source DB: PubMed Journal: Biochimie ISSN: 0300-9084 Impact factor: 4.079